Literature DB >> 22700831

Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile.

Christopher R Polage1, Jay V Solnick, Stuart H Cohen.   

Abstract

Diarrhea is common among hospitalized patients but the causes are distinct from those of diarrhea in the community. We review existing data about the epidemiology of nosocomial diarrhea and summarize recent progress in understanding the mechanisms of diarrhea. Clinicians should recognize that most cases of nosocomial diarrhea have a noninfectious etiology, including medications, underlying illness, and enteral feeding. Apart from Clostridium difficile, the frequency of infectious causes such as norovirus and toxigenic strains of Clostridium perfringens, Klebsiella oxytoca, Staphylococcus aureus, and Bacteroides fragilis remains largely undefined and test availability is limited. Here we provide a practical approach to the evaluation and management of nosocomial diarrhea when tests for C. difficile are negative.

Entities:  

Mesh:

Year:  2012        PMID: 22700831      PMCID: PMC3657522          DOI: 10.1093/cid/cis551

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  51 in total

1.  Antibiotic-associated diarrhea accompanied by large-scale alterations in the composition of the fecal microbiota.

Authors:  Vincent B Young; Thomas M Schmidt
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

2.  Role of Klebsiella oxytoca in antibiotic-associated diarrhea.

Authors:  Ines Zollner-Schwetz; Christoph Högenauer; Martina Joainig; Paul Weberhofer; Gregor Gorkiewicz; Thomas Valentin; Thomas A Hinterleitner; Robert Krause
Journal:  Clin Infect Dis       Date:  2008-11-01       Impact factor: 9.079

3.  Severe diarrhea in renal transplant patients: results of the DIDACT study.

Authors:  B Maes; K Hadaya; B de Moor; P Cambier; P Peeters; J de Meester; J Donck; J Sennesael; J-P Squifflet
Journal:  Am J Transplant       Date:  2006-06       Impact factor: 8.086

4.  Diarrhea in neutropenic patients: a prospective cohort study with emphasis on neutropenic enterocolitis.

Authors:  D Y Aksoy; M D Tanriover; O Uzun; P Zarakolu; S Ercis; S Ergüven; A Oto; U Kerimoglu; M Hayran; O Abbasoglu
Journal:  Ann Oncol       Date:  2006-10-05       Impact factor: 32.976

5.  Chemotherapy-induced diarrhea: pathophysiology, frequency and guideline-based management.

Authors:  Alexander Stein; Wieland Voigt; Karin Jordan
Journal:  Ther Adv Med Oncol       Date:  2010-01       Impact factor: 8.168

Review 6.  Diarrhoea in the critically ill.

Authors:  Patricia Wiesen; André Van Gossum; Jean-Charles Preiser
Journal:  Curr Opin Crit Care       Date:  2006-04       Impact factor: 3.687

Review 7.  Safety of probiotics: translocation and infection.

Authors:  Min-Tze Liong
Journal:  Nutr Rev       Date:  2008-04       Impact factor: 7.110

8.  Etiology and outcome of diarrhea after marrow transplantation: a prospective study.

Authors:  G J Cox; S M Matsui; R S Lo; M Hinds; R A Bowden; R C Hackman; W G Meyer; M Mori; P I Tarr; L S Oshiro
Journal:  Gastroenterology       Date:  1994-11       Impact factor: 22.682

9.  Gastrointestinal toxicity and Clostridium difficile diarrhea in patients treated with paclitaxel-containing chemotherapy regimens.

Authors:  A Husain; L Aptaker; D R Spriggs; R R Barakat
Journal:  Gynecol Oncol       Date:  1998-10       Impact factor: 5.482

10.  Epidemiology and cost of nosocomial gastroenteritis, Avon, England, 2002-2003.

Authors:  Ben A Lopman; Mark H Reacher; Ian B Vipond; Dawn Hill; Christine Perry; Tracey Halladay; David W Brown; W John Edmunds; Joyshri Sarangi
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

View more
  37 in total

1.  Implementation of a Clinical Decision Support Tool for Stool Cultures and Parasitological Studies in Hospitalized Patients.

Authors:  D Nikolic; S S Richter; K Asamoto; R Wyllie; R Tuttle; G W Procop
Journal:  J Clin Microbiol       Date:  2017-09-27       Impact factor: 5.948

2.  Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection?

Authors:  Ferric C Fang; Christopher R Polage; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2017-01-11       Impact factor: 5.948

3.  The impact of orally administered phages on host immune response and surrounding microbial communities.

Authors:  Yingying Hong; Jyothi Thimmapuram; Jiayi Zhang; Clayton K Collings; Ketaki Bhide; Kyle Schmidt; Paul D Ebner
Journal:  Bacteriophage       Date:  2016-07-13

4.  Novel portable platform for molecular detection of toxigenic Clostridium difficile in faeces: a diagnostic accuracy study.

Authors:  J J Hirvonen; P Matero; C Siebert; J Kauppila; R Vuento; H Tuokko; S Boisset
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-17       Impact factor: 3.267

5.  The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009-2015).

Authors:  Kevin C Katz; George R Golding; Kelly Baekyung Choi; Linda Pelude; Kanchana R Amaratunga; Monica Taljaard; Stephanie Alexandre; Jun Chen Collet; Ian Davis; Tim Du; Gerald A Evans; Charles Frenette; Denise Gravel; Susy Hota; Pamela Kibsey; Joanne M Langley; Bonita E Lee; Camille Lemieux; Yves Longtin; Dominik Mertz; Lorraine Maze Dit Mieusement; Jessica Minion; Dorothy L Moore; Michael R Mulvey; Susan Richardson; Michelle Science; Andrew E Simor; Paula Stagg; Kathryn N Suh; Geoffrey Taylor; Alice Wong; Nisha Thampi
Journal:  CMAJ       Date:  2018-06-25       Impact factor: 8.262

6.  Molecular-based diagnosis of Clostridium difficile infection is associated with reduced mortality.

Authors:  Tomer Avni; Tanya Babich; Haim Ben-Zvi; Alaa Atamna; Dafna Yahav; Daniel Shepshelovich; Yaara Leibovici-Weissman; Jihad Bishara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-04-07       Impact factor: 3.267

Review 7.  Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.

Authors:  Leon Fisher; Alexander Fisher
Journal:  Clin Drug Investig       Date:  2017-07       Impact factor: 2.859

8.  The HtrA-like protease CD3284 modulates virulence of Clostridium difficile.

Authors:  Dennis Bakker; Anthony M Buckley; Anne de Jong; Vincent J C van Winden; Joost P A Verhoeks; Oscar P Kuipers; Gillian R Douce; Ed J Kuijper; Wiep Klaas Smits; Jeroen Corver
Journal:  Infect Immun       Date:  2014-07-21       Impact factor: 3.441

9.  Toxin positivity and tcdB gene load in broad-spectrum Clostridium difficile infection.

Authors:  Hyeong Nyeon Kim; Hanah Kim; Hee-Won Moon; Mina Hur; Yeo-Min Yun
Journal:  Infection       Date:  2017-12-07       Impact factor: 3.553

Review 10.  Ultrasensitive Clostridioides difficile Toxin Testing for Higher Diagnostic Accuracy.

Authors:  Johanna Sandlund; Kerrie Davies; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.